UBS starts AbCellera at buy on menopause drug
Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash
UBS initiated coverage on AbCellera Biologics with a Buy rating and an Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context